Lucas Arruda

Company: CuraCell Holding AB

Job title: Chief Scientific Officer

Seminars:

Understanding the State-of-Play of TIL Therapies Beyond Melanoma 9:30 am

Evaluating the unique antigenic landscapes and immune responses that hinder the translation of TIL therapies from melanoma to other tumor types Discussing innovative approaches to enhance TIL therapy efficacy across different tumor types Reviewing recent research and clinicalRead more

day: Workshop Day R&D Track AM